Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
June 16, 2004
Preparation of immunoconjugates using antibody oligosaccharide moieties
Carl-Wilhelm Vogel
Frontiers in Cell and Developmental Biology
|
January 11, 2021
The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target
Carl-Wilhelm Vogel
Hawaii Medical Journal
|
June 21, 2002
The role of NCI-designated cancer centers in the nation's fight against cancer
Sharon Shigemasa, Carl-Wilhelm Vogel
Current Pharmaceutical Design
|
November 6, 2007
Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion
Carl-Wilhelm Vogel, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology
|
April 23, 2013
The 17th World Congress of the International Society on Toxinology and Venom Week 2012
Carl-Wilhelm Vogel, Steven A Seifert
Toxicon : Official Journal of the International Society on Toxinology
|
April 27, 2010
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion
Carl-Wilhelm Vogel, David C Fritzinger
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health
|
January 29, 2014
University of Hawai'i Cancer Center Connection: regional cooperation in addressing cancer health disparities: NCI's Geographic Management Program (GMaP) and Biospecimen Management Program (BMaP) in Western States, Hawai'i, and US pacific territories
Hali R Robinett, Heidi Harbach, Carl-Wilhelm Vogel
Cancer Science
|
September 27, 2006
Actin-binding protein filamin A is displayed on the surface of human neuroblastoma cells
André S Bachmann, James P Howard, Carl-Wilhelm Vogel
Molecular Immunology
|
July 27, 2014
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models
Carl-Wilhelm Vogel, Paul W Finnegan, David C Fritzinger
Hawaii Medical Journal
|
June 12, 2010
A partnership between the cancer research center of Hawaii and the University of Guam in Cancer Research, Education, Training, and Outreach
Carl-Wilhelm Vogel, Helen J D Whippy, Neal R Robinett
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Methods in Molecular Biology (Clifton, N.J.)
|
June 16, 2004
Preparation of immunoconjugates using antibody oligosaccharide moieties
Carl-Wilhelm Vogel
Frontiers in Cell and Developmental Biology
|
January 11, 2021
The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target
Carl-Wilhelm Vogel
Hawaii Medical Journal
|
June 21, 2002
The role of NCI-designated cancer centers in the nation's fight against cancer
Sharon Shigemasa, Carl-Wilhelm Vogel
Current Pharmaceutical Design
|
November 6, 2007
Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion
Carl-Wilhelm Vogel, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology
|
April 23, 2013
The 17th World Congress of the International Society on Toxinology and Venom Week 2012
Carl-Wilhelm Vogel, Steven A Seifert
Toxicon : Official Journal of the International Society on Toxinology
|
April 27, 2010
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion
Carl-Wilhelm Vogel, David C Fritzinger
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health
|
January 29, 2014
University of Hawai'i Cancer Center Connection: regional cooperation in addressing cancer health disparities: NCI's Geographic Management Program (GMaP) and Biospecimen Management Program (BMaP) in Western States, Hawai'i, and US pacific territories
Hali R Robinett, Heidi Harbach, Carl-Wilhelm Vogel
Cancer Science
|
September 27, 2006
Actin-binding protein filamin A is displayed on the surface of human neuroblastoma cells
André S Bachmann, James P Howard, Carl-Wilhelm Vogel
Molecular Immunology
|
July 27, 2014
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models
Carl-Wilhelm Vogel, Paul W Finnegan, David C Fritzinger
Hawaii Medical Journal
|
June 12, 2010
A partnership between the cancer research center of Hawaii and the University of Guam in Cancer Research, Education, Training, and Outreach
Carl-Wilhelm Vogel, Helen J D Whippy, Neal R Robinett
Page
of 3